BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help
Search Results
Documents 1-5 out of 5 found
  Current Search:  visudyne: 5     
HTML
100%
Combination therapy with verteporfin and anti-VEGF agents in neovascular age-related macular degeneration: where do we stand?
Choroidal neovascularisation (CNV) secondary to age-related macular degeneration (AMD) is responsible for 75% of the severe vision loss attributable to AMD.1 The pathogenesis of CNV is complex, involving angiogenic and vascular components.2 3 The current...
British Journal of Ophthalmology:  Feb 5 2010 5:04PM
Matching: visudyne 		Find similar documents
HTML
100%
Tekmira Pharmaceuticals Appoints New Chairman and Two New Independent Directors
Kisner is currently a Venture Partner at Aberdare Ventures, a leading US healthcare investor.

He is a physician and former tenured professor with significant industry experience and a successful track record leading development-stage biotechnology companies....

Marketwire via Yahoo!:  Jan 28 2010 10:06PM
Matching: visudyne 		Find similar documents
HTML
100%
New vascular endothelial growth factor data have been reported by scientists at Firat University
- (Rx.com) According to recent research from Elazig, Turkey, 'We aimed to determine the extent of protection provided by Visudyne eyeglass against vascular endothelial growth factor (VEGF) synthesis following photodynamic therapy (PDT) (see also Vascular...
Pharmacy Choice:  Jan 22 2010 12:10PM
Matching: visudyne 		Find similar documents
HTML
100%
QLT Inc. Establishes Sales Force in the United States
- QLT Ophthalmics, Inc.

will market Visudyne(R) to retinal specialists across the U.S.- VANCOUVER, Dec.

22 /CNW/ - QLT Inc.

(NASDAQ: QLTI; TSX: QLT) ('QLT' or the 'Company') is pleased to announce the establishment of its commercial presence in the United...

Drugs.com:  Jan 2 2010 1:12PM
Matching: visudyne 		Find similar documents
HTML
100%
QLT settles litigation with General Hospital Corporation
QLT Inc announced the settlement of its litigation with the General Hospital Corporation, doing business as Massachusetts General Hospital (MGH).

Under the terms of the settlement agreement, QLT will pay US$ 20.0 million to MGH as payment in full for all past...

PharmaBiz:  Nov 27 2009 10:55AM
Matching: visudyne 		Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.